Literature DB >> 23489663

Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.

Nobuyuki Murakami1, Yukiko K Hayashi, Yuji Oto, Masahisa Shiraishi, Hisashi Itabashi, Kyoko Kudo, Ichizo Nishino, Ikuya Nonaka, Toshiro Nagai.   

Abstract

A boy with congenital generalized lipodystrophy type 4 with muscular dystrophy presented in infancy with delay in motor milestones and a persistent elevation of CK. There was no associated mental retardation. He was followed up to 3 years and 11 months; he had a homozygous c.696_697insC mutation in polymerase I and transcript release factor (PTRF). He started to walk at 2 years and 6 months although he did not have mental retardation. Insulin resistance appeared at 3 years and 11 months of age. PTRF immunostaining positivity was absent in the muscle but caveolin-3 was preserved in the sarcolemma at 16 months of age. Secondary deficiency of caveolins may be closely associated with disease progression.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489663     DOI: 10.1016/j.nmd.2013.02.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Acetylation of Cavin-1 Promotes Lipolysis in White Adipose Tissue.

Authors:  Shui-Rong Zhou; Liang Guo; Xu Wang; Yang Liu; Wan-Qiu Peng; Yuan Liu; Xiang-Bo Wei; Xin Dou; Meng Ding; Qun-Ying Lei; Shu-Wen Qian; Xi Li; Qi-Qun Tang
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

2.  Muscular dystrophy in PTFR/cavin-1 null mice.

Authors:  Shi-Ying Ding; Libin Liu; Paul F Pilch
Journal:  JCI Insight       Date:  2017-03-09

3.  Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.

Authors:  Baris Akinci; Huseyin Onay; Tevfik Demir; Samim Ozen; Hulya Kayserili; Gulcin Akinci; Banu Nur; Beyhan Tuysuz; Mehmet Nuri Ozbek; Adem Gungor; Ilgin Yildirim Simsir; Canan Altay; Leyla Demir; Enver Simsek; Murat Atmaca; Haluk Topaloglu; Habib Bilen; Hulusi Atmaca; Tahir Atik; Umit Cavdar; Umut Altunoglu; Ayca Aslanger; Ercan Mihci; Mustafa Secil; Fusun Saygili; Abdurrahman Comlekci; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2016-05-04       Impact factor: 5.958

4.  Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy.

Authors:  Bing Han; Courtney A Copeland; Yumeko Kawano; Erika Berman Rosenzweig; Eric D Austin; Layla Shahmirzadi; Sha Tang; Krishnan Raghunathan; Wendy K Chung; Anne K Kenworthy
Journal:  Traffic       Date:  2016-11-02       Impact factor: 6.215

5.  Activation of PPARγ Ameliorates Spatial Cognitive Deficits through Restoring Expression of AMPA Receptors in Seipin Knock-Out Mice.

Authors:  Libin Zhou; Tingting Chen; Guoxi Li; Chaoming Wu; Conghui Wang; Lin Li; Sha Sha; Lei Chen; George Liu; Ling Chen
Journal:  J Neurosci       Date:  2016-01-27       Impact factor: 6.167

6.  Targeting phospholipid metabolism for glioblastoma therapy.

Authors:  Tianzhi Huang; Shi-Yuan Cheng
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

7.  Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy.

Authors:  Anna Ardissone; Cinzia Bragato; Lorella Caffi; Flavia Blasevich; Sabrina Maestrini; Maria Luisa Bianchi; Lucia Morandi; Isabella Moroni; Marina Mora
Journal:  BMC Med Genet       Date:  2013-09-11       Impact factor: 2.103

8.  Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant.

Authors:  Ekaterina Sorkina; Polina Makarova; Liubov Bolotskaya; Irina Ulyanova; Tatyana Chernova; Anatoly Tiulpakov
Journal:  Clin Diabetes Endocrinol       Date:  2020-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.